25 XP   0   0   10

Abivax SA
Buy, Hold or Sell?

Let's analyse Abivax together

PenkeI guess you are interested in Abivax SA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Abivax SA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Abivax SA

I send you an email if I find something interesting about Abivax SA.

Quick analysis of Abivax (30 sec.)










What can you expect buying and holding a share of Abivax? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€0.14
Expected worth in 1 year
€-1.57
How sure are you?
28.6%

+ What do you gain per year?

Total Gains per Share
€-1.71
Return On Investment
-13.0%

For what price can you sell your share?

Current Price per Share
€13.12
Expected price per share
€10.06 - €15.00
How sure are you?
50%

1. Valuation of Abivax (5 min.)




Live pricePrice per Share (EOD)

€13.12

Intrinsic Value Per Share

€-6.32 - €-3.97

Total Value Per Share

€-6.18 - €-3.83

2. Growth of Abivax (5 min.)




Is Abivax growing?

Current yearPrevious yearGrowGrow %
How rich?$9.4m$38.5m-$29.1m-309.3%

How much money is Abivax making?

Current yearPrevious yearGrowGrow %
Making money-$75.5m-$44.7m-$30.8m-40.8%
Net Profit Margin0.0%-111,775.7%--

How much money comes from the company's main activities?

3. Financial Health of Abivax (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#829 / 1031

Most Revenue
#916 / 1031

Most Profit
#969 / 1031

Most Efficient
#371 / 1031

What can you expect buying and holding a share of Abivax? (5 min.)

Welcome investor! Abivax's management wants to use your money to grow the business. In return you get a share of Abivax.

What can you expect buying and holding a share of Abivax?

First you should know what it really means to hold a share of Abivax. And how you can make/lose money.

Speculation

The Price per Share of Abivax is €13.12. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Abivax.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Abivax, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.14. Based on the TTM, the Book Value Change Per Share is €-0.43 per quarter. Based on the YOY, the Book Value Change Per Share is €0.28 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Abivax.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-1.04-8.0%-1.04-8.0%-0.73-5.6%-0.64-4.9%-0.52-4.0%
Usd Book Value Change Per Share-0.46-3.5%-0.46-3.5%0.302.3%-0.14-1.0%0.020.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.46-3.5%-0.46-3.5%0.302.3%-0.14-1.0%0.020.2%
Usd Price Per Share6.61-6.61-30.18-22.40-17.32-
Price to Earnings Ratio-6.33--6.33--41.35--40.22--35.58-
Price-to-Total Gains Ratio-14.29--14.29-99.11--603.04--513.03-
Price to Book Ratio44.18-44.18-49.29-62.86-46.49-
Price-to-Total Gains Ratio-14.29--14.29-99.11--603.04--513.03-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share14.191904
Number of shares70
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.46-0.14
Usd Total Gains Per Share-0.46-0.14
Gains per Quarter (70 shares)-32.39-9.50
Gains per Year (70 shares)-129.55-38.01
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-130-1400-38-48
20-259-2700-76-86
30-389-4000-114-124
40-518-5300-152-162
50-648-6600-190-200
60-777-7900-228-238
70-907-9200-266-276
80-1036-10500-304-314
90-1166-11800-342-352
100-1295-13100-380-390

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.07.00.00.0%0.07.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%2.05.00.028.6%2.05.00.028.6%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.07.00.0%0.00.07.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%2.05.00.028.6%2.05.00.028.6%

Fundamentals of Abivax

About Abivax SA

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.

Fundamental data was last updated by Penke on 2024-03-27 14:29:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Abivax SA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Abivax earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Abivax to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that €0.00 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Abivax SA:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-111,775.7%+111,775.7%
TTM-5Y-78,495.5%+78,495.5%
5Y-78,495.5%10Y-73,710.5%-4,785.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--159.2%+159.2%
TTM--202.3%+202.3%
YOY-111,775.7%-263.0%-111,512.7%
5Y-78,495.5%-452.4%-78,043.1%
10Y-73,710.5%-589.0%-73,121.5%
1.1.2. Return on Assets

Shows how efficient Abivax is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Abivax to the Biotechnology industry mean.
  • -95.2% Return on Assets means that Abivax generated €-0.95 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Abivax SA:

  • The MRQ is -95.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -95.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-95.2%TTM-95.2%0.0%
TTM-95.2%YOY-37.5%-57.7%
TTM-95.2%5Y-54.8%-40.4%
5Y-54.8%10Y-45.5%-9.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-95.2%-12.5%-82.7%
TTM-95.2%-12.2%-83.0%
YOY-37.5%-11.2%-26.3%
5Y-54.8%-13.3%-41.5%
10Y-45.5%-14.6%-30.9%
1.1.3. Return on Equity

Shows how efficient Abivax is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Abivax to the Biotechnology industry mean.
  • -802.7% Return on Equity means Abivax generated €-8.03 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Abivax SA:

  • The MRQ is -802.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -802.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-802.7%TTM-802.7%0.0%
TTM-802.7%YOY-116.1%-686.6%
TTM-802.7%5Y-267.8%-534.9%
5Y-267.8%10Y-198.2%-69.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-802.7%-16.0%-786.7%
TTM-802.7%-15.8%-786.9%
YOY-116.1%-13.9%-102.2%
5Y-267.8%-18.2%-249.6%
10Y-198.2%-19.1%-179.1%

1.2. Operating Efficiency of Abivax SA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Abivax is operating .

  • Measures how much profit Abivax makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Abivax to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Abivax SA:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-132,762.2%+132,762.2%
TTM-5Y-89,307.0%+89,307.0%
5Y-89,307.0%10Y-86,014.1%-3,292.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.5%+299.5%
TTM--208.5%+208.5%
YOY-132,762.2%-280.2%-132,482.0%
5Y-89,307.0%-459.9%-88,847.1%
10Y-86,014.1%-596.9%-85,417.2%
1.2.2. Operating Ratio

Measures how efficient Abivax is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are €0.00 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Abivax SA:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY2,381.459-2,381.459
TTM-5Y1,100.319-1,100.319
5Y1,100.31910Y1,009.163+91.156
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.817-2.817
TTM-3.181-3.181
YOY2,381.4593.609+2,377.850
5Y1,100.3195.554+1,094.765
10Y1,009.1637.396+1,001.767

1.3. Liquidity of Abivax SA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Abivax is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.13 means the company has €1.13 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Abivax SA:

  • The MRQ is 1.126. The company is just able to pay all its short-term debts.
  • The TTM is 1.126. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.126TTM1.1260.000
TTM1.126YOY2.340-1.214
TTM1.1265Y1.870-0.744
5Y1.87010Y3.006-1.136
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1263.987-2.861
TTM1.1264.440-3.314
YOY2.3405.569-3.229
5Y1.8706.158-4.288
10Y3.0066.492-3.486
1.3.2. Quick Ratio

Measures if Abivax is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Abivax to the Biotechnology industry mean.
  • A Quick Ratio of 0.26 means the company can pay off €0.26 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Abivax SA:

  • The MRQ is 0.259. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.259. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.259TTM0.2590.000
TTM0.259YOY0.046+0.213
TTM0.2595Y0.512-0.253
5Y0.51210Y1.659-1.147
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2593.653-3.394
TTM0.2594.158-3.899
YOY0.0465.515-5.469
5Y0.5126.012-5.500
10Y1.6596.206-4.547

1.4. Solvency of Abivax SA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Abivax assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Abivax to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.88 means that Abivax assets are financed with 88.1% credit (debt) and the remaining percentage (100% - 88.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Abivax SA:

  • The MRQ is 0.881. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.881. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.881TTM0.8810.000
TTM0.881YOY0.677+0.204
TTM0.8815Y0.661+0.220
5Y0.66110Y0.497+0.165
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8810.336+0.545
TTM0.8810.330+0.551
YOY0.6770.267+0.410
5Y0.6610.367+0.294
10Y0.4970.378+0.119
1.4.2. Debt to Equity Ratio

Measures if Abivax is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Abivax to the Biotechnology industry mean.
  • A Debt to Equity ratio of 743.0% means that company has €7.43 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Abivax SA:

  • The MRQ is 7.430. The company is unable to pay all its debts with equity. -1
  • The TTM is 7.430. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ7.430TTM7.4300.000
TTM7.430YOY2.099+5.331
TTM7.4305Y2.971+4.459
5Y2.97110Y2.149+0.822
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.4300.376+7.054
TTM7.4300.398+7.032
YOY2.0990.334+1.765
5Y2.9710.431+2.540
10Y2.1490.476+1.673

2. Market Valuation of Abivax SA

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Abivax generates.

  • Above 15 is considered overpriced but always compare Abivax to the Biotechnology industry mean.
  • A PE ratio of -6.33 means the investor is paying €-6.33 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Abivax SA:

  • The EOD is -13.590. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.329. Based on the earnings, the company is expensive. -2
  • The TTM is -6.329. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-13.590MRQ-6.329-7.261
MRQ-6.329TTM-6.3290.000
TTM-6.329YOY-41.350+35.021
TTM-6.3295Y-40.224+33.895
5Y-40.22410Y-35.580-4.644
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-13.590-2.697-10.893
MRQ-6.329-2.422-3.907
TTM-6.329-2.709-3.620
YOY-41.350-4.116-37.234
5Y-40.224-6.257-33.967
10Y-35.580-6.478-29.102
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Abivax SA:

  • The EOD is -29.448. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -13.714. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -13.714. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-29.448MRQ-13.714-15.734
MRQ-13.714TTM-13.7140.000
TTM-13.714YOY-37.113+23.399
TTM-13.7145Y-44.358+30.644
5Y-44.35810Y-39.837-4.522
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-29.448-3.344-26.104
MRQ-13.714-2.939-10.775
TTM-13.714-3.486-10.228
YOY-37.113-5.592-31.521
5Y-44.358-8.464-35.894
10Y-39.837-8.872-30.965
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Abivax is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 44.18 means the investor is paying €44.18 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Abivax SA:

  • The EOD is 94.872. Based on the equity, the company is expensive. -2
  • The MRQ is 44.182. Based on the equity, the company is expensive. -2
  • The TTM is 44.182. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD94.872MRQ44.182+50.690
MRQ44.182TTM44.1820.000
TTM44.182YOY49.292-5.111
TTM44.1825Y62.856-18.674
5Y62.85610Y46.492+16.364
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD94.8722.198+92.674
MRQ44.1822.042+42.140
TTM44.1822.121+42.061
YOY49.2922.907+46.385
5Y62.8563.682+59.174
10Y46.4924.114+42.378
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Abivax SA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.428-0.4280%0.282-252%-0.125-71%0.020-2265%
Book Value Per Share--0.1380.1380%0.566-76%0.367-62%0.500-72%
Current Ratio--1.1261.1260%2.340-52%1.870-40%3.006-63%
Debt To Asset Ratio--0.8810.8810%0.677+30%0.661+33%0.497+78%
Debt To Equity Ratio--7.4307.4300%2.099+254%2.971+150%2.149+246%
Dividend Per Share----0%-0%-0%-0%
Eps---0.965-0.9650%-0.675-30%-0.595-38%-0.483-50%
Free Cash Flow Per Share---0.446-0.4460%-0.752+69%-0.476+7%-0.399-11%
Free Cash Flow To Equity Per Share--0.0660.0660%0.562-88%0.160-59%0.062+7%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---3.972--------
Intrinsic Value_10Y_min---6.321--------
Intrinsic Value_1Y_max---0.460--------
Intrinsic Value_1Y_min---0.586--------
Intrinsic Value_3Y_max---1.336--------
Intrinsic Value_3Y_min---1.812--------
Intrinsic Value_5Y_max---2.154--------
Intrinsic Value_5Y_min---3.085--------
Market Cap825477600.000+53%384425925.000384425925.0000%1755398250.000-78%1302769755.000-70%1007408045.357-62%
Net Profit Margin----0%-1117.7570%-784.9550%-737.1050%
Operating Margin----0%-1327.6220%-893.0700%-860.1410%
Operating Ratio----0%2381.459-100%1100.319-100%1009.163-100%
Pb Ratio94.872+53%44.18244.1820%49.292-10%62.856-30%46.492-5%
Pe Ratio-13.590-115%-6.329-6.3290%-41.350+553%-40.224+536%-35.580+462%
Price Per Share13.120+53%6.1106.1100%27.900-78%20.706-70%16.012-62%
Price To Free Cash Flow Ratio-29.448-115%-13.714-13.7140%-37.113+171%-44.358+223%-39.837+190%
Price To Total Gains Ratio-30.674-115%-14.285-14.2850%99.108-114%-603.037+4121%-513.034+3491%
Quick Ratio--0.2590.2590%0.046+465%0.512-49%1.659-84%
Return On Assets---0.952-0.9520%-0.375-61%-0.548-42%-0.455-52%
Return On Equity---8.027-8.0270%-1.161-86%-2.678-67%-1.982-75%
Total Gains Per Share---0.428-0.4280%0.282-252%-0.125-71%0.020-2265%
Usd Book Value--9411871.7009411871.7000%38521500.400-76%24978616.400-62%34051452.414-72%
Usd Book Value Change Per Share---0.463-0.4630%0.305-252%-0.136-71%0.021-2265%
Usd Book Value Per Share--0.1500.1500%0.612-76%0.397-62%0.541-72%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.044-1.0440%-0.730-30%-0.644-38%-0.522-50%
Usd Free Cash Flow---30322214.400-30322214.4000%-51163328.300+69%-32414654.880+7%-27133517.329-11%
Usd Free Cash Flow Per Share---0.482-0.4820%-0.813+69%-0.515+7%-0.431-11%
Usd Free Cash Flow To Equity Per Share--0.0720.0720%0.608-88%0.173-59%0.067+7%
Usd Market Cap892919119.920+53%415833523.073415833523.0730%1898814287.025-78%1409206043.984-70%1089713282.663-62%
Usd Price Per Share14.192+53%6.6096.6090%30.179-78%22.398-70%17.320-62%
Usd Profit---75552418.200-75552418.2000%-44735866.900-41%-42231947.740-44%-34110945.914-55%
Usd Revenue----0%40022.900-100%30503.940-100%42958.943-100%
Usd Total Gains Per Share---0.463-0.4630%0.305-252%-0.136-71%0.021-2265%
 EOD+5 -3MRQTTM+0 -0YOY+7 -245Y+7 -2410Y+6 -25

3.2. Fundamental Score

Let's check the fundamental score of Abivax SA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-13.590
Price to Book Ratio (EOD)Between0-194.872
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.259
Current Ratio (MRQ)Greater than11.126
Debt to Asset Ratio (MRQ)Less than10.881
Debt to Equity Ratio (MRQ)Less than17.430
Return on Equity (MRQ)Greater than0.15-8.027
Return on Assets (MRQ)Greater than0.05-0.952
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Abivax SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.231
Ma 20Greater thanMa 5012.943
Ma 50Greater thanMa 10012.118
Ma 100Greater thanMa 20010.898
OpenGreater thanClose13.160
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets73,352
Total Liabilities64,651
Total Stockholder Equity8,701
 As reported
Total Liabilities 64,651
Total Stockholder Equity+ 8,701
Total Assets = 73,352

Assets

Total Assets73,352
Total Current Assets36,181
Long-term Assets25,161
Total Current Assets
Cash And Cash Equivalents 26,944
Short-term Investments 6
Net Receivables 8,316
Total Current Assets  (as reported)36,181
Total Current Assets  (calculated)35,266
+/- 915
Long-term Assets
Property Plant Equipment 323
Goodwill 36,663
Intangible Assets -13,138
Long-term Assets Other -2
Long-term Assets  (as reported)25,161
Long-term Assets  (calculated)23,846
+/- 1,315

Liabilities & Shareholders' Equity

Total Current Liabilities32,132
Long-term Liabilities36,614
Total Stockholder Equity8,701
Total Current Liabilities
Short Long Term Debt 9,491
Accounts payable 15,466
Other Current Liabilities 255
Total Current Liabilities  (as reported)32,132
Total Current Liabilities  (calculated)25,212
+/- 6,920
Long-term Liabilities
Long term Debt 36,575
Other Liabilities 1,215
Long-term Liabilities Other -1
Long-term Liabilities  (as reported)36,614
Long-term Liabilities  (calculated)37,789
+/- 1,175
Total Stockholder Equity
Common Stock223
Retained Earnings -60,740
Total Stockholder Equity (as reported)8,701
Total Stockholder Equity (calculated)-60,517
+/- 69,218
Other
Capital Stock223
Common Stock Shares Outstanding 22,301
Net Debt 19,122
Net Invested Capital 54,767
Net Tangible Assets -17,837
Net Working Capital 20,154
Property Plant and Equipment Gross 841



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
60,597
53,815
54,048
51,728
71,298
110,365
73,352
73,352110,36571,29851,72854,04853,81560,597
   > Total Current Assets 
27,841
20,876
20,977
18,244
37,667
75,485
36,181
36,18175,48537,66718,24420,97720,87627,841
       Cash And Cash Equivalents 
22,987
17,032
13,002
9,771
29,302
60,695
26,944
26,94460,69529,3029,77113,00217,03222,987
       Short-term Investments 
15,050
15,151
5,006
6
6
6
6
66665,00615,15115,050
       Net Receivables 
4,803
3,647
7,775
8,131
1,786
1,472
8,316
8,3161,4721,7868,1317,7753,6474,803
       Other Current Assets 
-1
11
-1
3,729
1
5,729
0
05,72913,729-111-1
   > Long-term Assets 
32,757
32,939
33,071
33,483
33,630
35,153
25,161
25,16135,15333,63033,48333,07132,93932,757
       Property Plant Equipment 
191
202
151
134
100
93
323
32393100134151202191
       Goodwill 
32,005
32,005
32,005
0
32,745
32,745
36,663
36,66332,74532,745032,00532,00532,005
       Intangible Assets 
0
0
0
32,090
32,102
-647
-13,138
-13,138-64732,10232,090000
       Other Assets 
560
1
915
1,260
1,428
1,342
12,745
12,7451,3421,4281,2609151560
> Total Liabilities 
3,880
5,635
19,393
33,136
53,398
74,753
64,651
64,65174,75353,39833,13619,3935,6353,880
   > Total Current Liabilities 
3,547
5,435
8,492
12,388
19,407
32,265
32,132
32,13232,26519,40712,3888,4925,4353,547
       Short Long Term Debt 
255
170
10,900
20,743
5,549
7
9,491
9,49175,54920,74310,900170255
       Accounts payable 
2,571
4,219
6,654
10,545
17,408
18,551
15,466
15,46618,55117,40810,5456,6544,2192,571
       Other Current Liabilities 
976
1,124
1,838
1,843
1,999
412
255
2554121,9991,8431,8381,124976
   > Long-term Liabilities 
333
292
10,900
20,743
28,454
53,543
36,614
36,61453,54328,45420,74310,900292333
       Long term Debt 
316
262
10,900
20,743
28,445
53,445
36,575
36,57553,44528,44520,74310,900262316
       Other Liabilities 
17
200
2
5
9
10,723
1,215
1,21510,72395220017
       Long-term Liabilities Other 
1
3
1
5
8
0
-1
-1085131
> Total Stockholder Equity
56,717
48,180
34,655
18,592
17,900
35,612
8,701
8,70135,61217,90018,59234,65548,18056,717
   Common Stock
97
99
102
122
143
168
223
2231681431221029997
   Retained Earnings Total Equity0000000
   Accumulated Other Comprehensive Income 0000000
   Capital Surplus 0000000
   Treasury Stock0000000
   Other Stockholders Equity 
2,439
4,517
6,193
7,099
13,518
-39,360
-82,770
-82,770-39,36013,5187,0996,1934,5172,439



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-110
Gross Profit-110-110
 
Operating Income (+$)
Gross Profit-110
Operating Expense-56,647
Operating Income-56,647-56,757
 
Operating Expense (+$)
Research Development0
Selling General Administrative49,606
Selling And Marketing Expenses0
Operating Expense56,64749,606
 
Net Interest Income (+$)
Interest Income128
Interest Expense-3,696
Other Finance Cost-238
Net Interest Income-3,806
 
Pretax Income (+$)
Operating Income-56,647
Net Interest Income-3,806
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-74,323-56,647
EBIT - interestExpense = -54,929
-69,846
-66,150
Interest Expense3,696
Earnings Before Interest and Taxes (EBIT)-51,233-70,627
Earnings Before Interest and Taxes (EBITDA)-70,318
 
After tax Income (+$)
Income Before Tax-74,323
Tax Provision--4,476
Net Income From Continuing Ops-69,847-69,847
Net Income-69,846
Net Income Applicable To Common Shares-60,740
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses4,554
Total Other Income/Expenses Net03,806
 

Technical Analysis of Abivax
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Abivax. The general trend of Abivax is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Abivax's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Abivax SA.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 13.64 < 14.44 < 15.00.

The bearish price targets are: 11.82 > 10.92 > 10.06.

Tweet this
Abivax SA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Abivax SA. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Abivax SA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Abivax SA. The current macd is 0.31866408.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Abivax price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Abivax. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Abivax price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Abivax SA Daily Moving Average Convergence/Divergence (MACD) ChartAbivax SA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Abivax SA. The current adx is 30.64.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Abivax shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Abivax SA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Abivax SA. The current sar is 12.03.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Abivax SA Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Abivax SA. The current rsi is 55.23. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Abivax SA Daily Relative Strength Index (RSI) ChartAbivax SA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Abivax SA. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Abivax price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Abivax SA Daily Stochastic Oscillator ChartAbivax SA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Abivax SA. The current cci is 38.76.

Abivax SA Daily Commodity Channel Index (CCI) ChartAbivax SA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Abivax SA. The current cmo is 8.08226374.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Abivax SA Daily Chande Momentum Oscillator (CMO) ChartAbivax SA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Abivax SA. The current willr is -28.57142857.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Abivax is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Abivax SA Daily Williams %R ChartAbivax SA Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Abivax SA.

Abivax SA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Abivax SA. The current atr is 0.39328705.

Abivax SA Daily Average True Range (ATR) ChartAbivax SA Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Abivax SA. The current obv is -16,385.

Abivax SA Daily On-Balance Volume (OBV) ChartAbivax SA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Abivax SA. The current mfi is 48.57.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Abivax SA Daily Money Flow Index (MFI) ChartAbivax SA Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Abivax SA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-09 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-10 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-15 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-17 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-20 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-22 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-27 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-29 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-01 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-14 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-15 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-27 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28 00:00:00MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-03 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-18 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-26 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-08 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-19 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-26 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-12 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-20 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-28 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Abivax SA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Abivax SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.231
Ma 20Greater thanMa 5012.943
Ma 50Greater thanMa 10012.118
Ma 100Greater thanMa 20010.898
OpenGreater thanClose13.160
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Abivax with someone you think should read this too:
  • Are you bullish or bearish on Abivax? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Abivax? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Abivax SA

I send you an email if I find something interesting about Abivax SA.


Comments

How you think about this?

Leave a comment

Stay informed about Abivax SA.

Receive notifications about Abivax SA in your mailbox!